Joint Formulary & PAD

Risedronate sodium - Paget's disease

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :
Important

30mg tablets are licensed for Paget's disease.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Risedronate sodium
Indication :
Paget's disease
Group Name :
Keywords :
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Risedronate sodium is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Paget's disease.

Committee Recommendations (0)

  • No records returned.